Compare $APYX vs $LUCD | Chartloom

Compare

$APYX vs $LUCD

Apyx Medical Inc · Lucid Diagnostics Inc

APYX

Apyx Medical Inc

LUCD

Lucid Diagnostics Inc

Compare $APYX vs $LUCD

Comparing Apyx Medical Inc and Lucid Diagnostics Inc

APYXApyx Medical Inc

LUCDLucid Diagnostics Inc

APYXApyx Medical Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1.73x

Rev growth (TTM)

25.6%

YTD performance

-26.0%

52W performance

-9.8%

FCF yield

-10.2%

LUCDLucid Diagnostics Inc

Market cap

$122M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

13.06x

Rev growth (TTM)

24.9%

YTD performance

-43.0%

52W performance

-47.7%

FCF yield

-38.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APYX

LUCD

Detailed metrics comparison

APYX

Apyx Medical Inc

LUCD

Lucid Diagnostics Inc

Market Cap

APYX$109M

LUCD$122M

Enterprise Value

APYX$116M

LUCD$112M

Price

APYX$2.59

LUCD$0.64

P/E Ratio

APYXN/A

LUCDN/A

P/S Ratio

APYX1.86x

LUCD22.35x

EV/Sales

APYX1.99x

LUCD20.53x

EV/EBITDA

APYX166.88x

LUCD0.00x

P/B Ratio

APYX10.07x

LUCD11.67x

P/FCF Ratio

APYXN/A

LUCDN/A

EV/FCF

APYX-10.53x

LUCD-2.37x

PEG Ratio

APYXN/A

LUCDN/A

Forward P/E (NTM)

APYXN/A

LUCDN/A

Forward P/S (NTM)

APYX1.73x

LUCD13.06x

Revenue (TTM)

APYX$58M

LUCD$5M

Revenue Growth (YoY)

APYX25.6%

LUCD24.9%

Forward Rev Growth

APYX11.1%

LUCD163.5%

Gross Margin (TTM)

APYX63.5%

LUCD-21.7%

Operating Margin (TTM)

APYX0.0%

LUCD0.0%

EBITDA Margin (TTM)

APYX-4.7%

LUCD-914.8%

Net Margin (TTM)

APYX-14.8%

LUCD-1193.9%

FCF Margin (TTM)

APYX-18.9%

LUCD-866.6%

Net Income (TTM)

APYX$-9M

LUCD$-65M

FCF (TTM)

APYX$-11M

LUCD$-47M

EPS (TTM)

APYX-$0.20

LUCD-$0.35

ROE (TTM)

APYX-7870.0%

LUCD-40434.0%

ROA (TTM)

APYX-1391.0%

LUCD-12542.0%

ROIC (TTM)

APYX-1878.0%

LUCD-14249.0%

Cash

APYX$28M

LUCD$33M

Debt

APYX$35M

LUCD$24M

Net Cash/Debt

APYX$-8M

LUCD$10M

Current Ratio (TTM)

APYX5.68x

LUCD1.33x

Quick Ratio (TTM)

APYX4.41x

LUCD1.29x

Debt/Equity (TTM)

APYX3.32x

LUCD2.15x

Debt/Assets (TTM)

APYX0.0%

LUCD0.0%

Interest Coverage (TTM)

APYXN/A

LUCDN/A

Net Debt/EBITDA (TTM)

APYX0.00x

LUCD0.00x

Beta

APYX1.53

LUCD1.16

52W Performance

APYX-9.8%

LUCD-47.7%

YTD Performance

APYX-26.0%

LUCD-43.0%

% from 52W High

APYX-49.0%

LUCD-60.8%

% from 52W Low

APYX11.6%

LUCD27.6%

Asset Turnover (TTM)

APYX0.94x

LUCD0.13x

FCF Yield (TTM)

APYX-10.2%

LUCD-38.8%

Earnings Yield (TTM)

APYX-8.0%

LUCD-53.4%

Dividend Yield (TTM)

APYXN/A

LUCDN/A

Rule of 40

APYX6.7

LUCD-841.7

EV/GP/RG

APYX0.41

LUCDN/A

Ticker research

View APYX research View LUCD research

Metric	APYX Apyx Medical Inc	LUCD Lucid Diagnostics Inc
Market & Valuation
Market Cap	$109M	$122M
Enterprise Value	$116M	$112M
Price	$2.59	$0.64
P/E Ratio	N/A	N/A
P/S Ratio	1.86x	22.35x
EV/Sales	1.99x	20.53x
EV/EBITDA	166.88x	0.00x
P/B Ratio	10.07x	11.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.53x	-2.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.73x	13.06x
Revenue & Growth
Revenue (TTM)	$58M	$5M
Revenue Growth (YoY)	25.6%	24.9%
Forward Rev Growth	11.1%	163.5%
Profitability
Gross Margin (TTM)	63.5%	-21.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4.7%	-914.8%
Net Margin (TTM)	-14.8%	-1193.9%
FCF Margin (TTM)	-18.9%	-866.6%
Net Income (TTM)	$-9M	$-65M
FCF (TTM)	$-11M	$-47M
EPS (TTM)	-$0.20	-$0.35
ROE (TTM)	-7870.0%	-40434.0%
ROA (TTM)	-1391.0%	-12542.0%
ROIC (TTM)	-1878.0%	-14249.0%
Financial Health
Cash	$28M	$33M
Debt	$35M	$24M
Net Cash/Debt	$-8M	$10M
Current Ratio (TTM)	5.68x	1.33x
Quick Ratio (TTM)	4.41x	1.29x
Debt/Equity (TTM)	3.32x	2.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	1.16
52W Performance	-9.8%	-47.7%
YTD Performance	-26.0%	-43.0%
% from 52W High	-49.0%	-60.8%
% from 52W Low	11.6%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.94x	0.13x
FCF Yield (TTM)	-10.2%	-38.8%
Earnings Yield (TTM)	-8.0%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	6.7	-841.7
EV/GP/RG	0.41	N/A
Ticker research	View APYX research	View LUCD research

Valuation

P/S Ratio

APYX

1.86x

LUCD

22.35x

EV/FCF

APYX

-10.53x

LUCD

-2.37x

Growth & revenue

Revenue Growth TTM

APYX

25.6%

LUCD

24.9%

Forward Revenue Growth

LUCD

163.5%

APYX

11.1%

Profitability & performance

Gross Margin

APYX

63.5%

LUCD

-21.7%

ROE

APYX

-7870.0%

LUCD

-40434.0%

FCF Yield %

APYX

-10.2%

LUCD

-38.8%

52-Week Performance

APYX

-9.8%

LUCD

-47.7%

Detailed metrics comparison

APYX

Apyx Medical Inc

LUCD

Lucid Diagnostics Inc

Market Cap

APYX$109M

LUCD$122M

Enterprise Value

APYX$116M

LUCD$112M

Price

APYX$2.59

LUCD$0.64

P/E Ratio

APYXN/A

LUCDN/A

P/S Ratio

APYX1.86x

LUCD22.35x

EV/Sales

APYX1.99x

LUCD20.53x

EV/EBITDA

APYX166.88x

LUCD0.00x

P/B Ratio

APYX10.07x

LUCD11.67x

P/FCF Ratio

APYXN/A

LUCDN/A

EV/FCF

APYX-10.53x

LUCD-2.37x

PEG Ratio

APYXN/A

LUCDN/A

Forward P/E (NTM)

APYXN/A

LUCDN/A

Forward P/S (NTM)

APYX1.73x

LUCD13.06x

Revenue (TTM)

APYX$58M

LUCD$5M

Revenue Growth (YoY)

APYX25.6%

LUCD24.9%

Forward Rev Growth

APYX11.1%

LUCD163.5%

Gross Margin (TTM)

APYX63.5%

LUCD-21.7%

Operating Margin (TTM)

APYX0.0%

LUCD0.0%

EBITDA Margin (TTM)

APYX-4.7%

LUCD-914.8%

Net Margin (TTM)

APYX-14.8%

LUCD-1193.9%

FCF Margin (TTM)

APYX-18.9%

LUCD-866.6%

Net Income (TTM)

APYX$-9M

LUCD$-65M

FCF (TTM)

APYX$-11M

LUCD$-47M

EPS (TTM)

APYX-$0.20

LUCD-$0.35

ROE (TTM)

APYX-7870.0%

LUCD-40434.0%

ROA (TTM)

APYX-1391.0%

LUCD-12542.0%

ROIC (TTM)

APYX-1878.0%

LUCD-14249.0%

Cash

APYX$28M

LUCD$33M

Debt

APYX$35M

LUCD$24M

Net Cash/Debt

APYX$-8M

LUCD$10M

Current Ratio (TTM)

APYX5.68x

LUCD1.33x

Quick Ratio (TTM)

APYX4.41x

LUCD1.29x

Debt/Equity (TTM)

APYX3.32x

LUCD2.15x

Debt/Assets (TTM)

APYX0.0%

LUCD0.0%

Interest Coverage (TTM)

APYXN/A

LUCDN/A

Net Debt/EBITDA (TTM)

APYX0.00x

LUCD0.00x

Beta

APYX1.53

LUCD1.16

52W Performance

APYX-9.8%

LUCD-47.7%

YTD Performance

APYX-26.0%

LUCD-43.0%

% from 52W High

APYX-49.0%

LUCD-60.8%

% from 52W Low

APYX11.6%

LUCD27.6%

Asset Turnover (TTM)

APYX0.94x

LUCD0.13x

FCF Yield (TTM)

APYX-10.2%

LUCD-38.8%

Earnings Yield (TTM)

APYX-8.0%

LUCD-53.4%

Dividend Yield (TTM)

APYXN/A

LUCDN/A

Rule of 40

APYX6.7

LUCD-841.7

EV/GP/RG

APYX0.41

LUCDN/A

Ticker research

View APYX research View LUCD research

Metric	APYX Apyx Medical Inc	LUCD Lucid Diagnostics Inc
Market & Valuation
Market Cap	$109M	$122M
Enterprise Value	$116M	$112M
Price	$2.59	$0.64
P/E Ratio	N/A	N/A
P/S Ratio	1.86x	22.35x
EV/Sales	1.99x	20.53x
EV/EBITDA	166.88x	0.00x
P/B Ratio	10.07x	11.67x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.53x	-2.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	1.73x	13.06x
Revenue & Growth
Revenue (TTM)	$58M	$5M
Revenue Growth (YoY)	25.6%	24.9%
Forward Rev Growth	11.1%	163.5%
Profitability
Gross Margin (TTM)	63.5%	-21.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4.7%	-914.8%
Net Margin (TTM)	-14.8%	-1193.9%
FCF Margin (TTM)	-18.9%	-866.6%
Net Income (TTM)	$-9M	$-65M
FCF (TTM)	$-11M	$-47M
EPS (TTM)	-$0.20	-$0.35
ROE (TTM)	-7870.0%	-40434.0%
ROA (TTM)	-1391.0%	-12542.0%
ROIC (TTM)	-1878.0%	-14249.0%
Financial Health
Cash	$28M	$33M
Debt	$35M	$24M
Net Cash/Debt	$-8M	$10M
Current Ratio (TTM)	5.68x	1.33x
Quick Ratio (TTM)	4.41x	1.29x
Debt/Equity (TTM)	3.32x	2.15x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.53	1.16
52W Performance	-9.8%	-47.7%
YTD Performance	-26.0%	-43.0%
% from 52W High	-49.0%	-60.8%
% from 52W Low	11.6%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.94x	0.13x
FCF Yield (TTM)	-10.2%	-38.8%
Earnings Yield (TTM)	-8.0%	-53.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	6.7	-841.7
EV/GP/RG	0.41	N/A
Ticker research	View APYX research	View LUCD research